ESE vs QRVO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ESE exhibits stable financial health with a Piotroski F-Score of 6/9 and an exceptionally low debt-to-equity ratio of 0.14. While revenue growth is robust at 35% YoY and earnings beats are consistent, the stock is trading at a severe premium, far exceeding its Graham Number ($80.68) and Intrinsic Value ($141.6). Heavy insider selling by the CEO and CFO, combined with a trailing P/E of 66.65, suggests the current price may have outpaced fundamental value. The strategic exit from the Space business and reliance on US Government defense spending add a layer of systemic risk despite strong analyst recommendations.
QRVO demonstrates exceptional fundamental health with a Piotroski F-Score of 8/9 and a very strong liquidity position (Current Ratio 3.67). While the current price of $85.84 is above the defensive Graham Number ($57.1), it trades at a significant discount to its growth-based intrinsic value of $107.08. The most compelling metric is the PEG ratio of 0.21, indicating the stock is severely undervalued relative to its explosive earnings growth. However, the bullish fundamental outlook is tempered by bearish insider selling and a negative technical trend.
Compare Another Pair
Related Comparisons
ESE vs QRVO: Head-to-Head Comparison
This page compares ESCO Technologies Inc. (ESE) and Qorvo, Inc. (QRVO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.